PDX INSIGHTS
PIONEERING CANCER RESEARCH
Home
Collections
Bladder
Breast
Leukemia
Liver - Pediatric
Pancreas
Sarcoma
Omics Tools
Management
Data Management
File Management
Drug Studies
Contact Us
Log In
You need to enable JavaScript to run this app page.
Leukemia
TCH-AML004
Model Details
Patient
PDX Model
Histology
Metastasis
Patient Treatment
Patient Information for Model: TCH-AML004
Contact Model Developer
Model Contact
Model: TCH-AML004
Model Contact: Alexandra Stevens
Institution: TCH Leukemia PDX Program
Email:
amsteven@texaschildrens.org
Patient Information
Clinical Timeline
Clinical Information at Collection
Clinical Biomarkers/Mutations
Model Information for Model: TCH-AML004
Model Details - Initial Implantation of Patient Tissue
Mutations (Cancer Gene Census List)
Mutation data is currently not available.
CNV
There are no omics data for this model.
Histology Information for Model: TCH-AML004
There are no histology images for this model.
Metastasis Information for Model: TCH-AML004
Patient
PDX
Abdomen
BM
Central Nervous System
Face
Gingiva
Kidney
Kidneys
L cheek
Leg
Liver
Lymph node
Orbital chloroma
PB
Pancreas
Periorbital
Retinas
Skin
Skull base
Spine
Spleen
Stomach
Tail
Temporal bone
Testis
Tongue
periorbital chloroma
sacrum
Patient Treatment Information for Model: TCH-AML004
Event Id
Treatment
Treatment Setting
Age at Start
Age at End
Duration
Clinical Response
Measurable Residual Disease
10
ADE10
De Novo
1.17
Unknown
Residual Disease
25%
15
ADE8
De Novo
1.25
Unknown
Residual Disease
2%
30
Vorino/Decitabine/FLAG
Refractory
1.37
Unknown
Residual Disease
1%
35
Vorino/Decitabine/FLAG
Refractory
1.45
Unknown
Residual Disease
1%
50
Vyxeos
Refractory
1.54
Unknown
Residual Disease
8%
60
Enasidanib
Refractory
1.65
Unknown
Residual Dissease
13%
Please wait...
